reports
- Jonathan Moreland
VIRC VIRCO MANUFACTURING CORP.
VALE.N VALE S.A. ADS
MKC MCCORMICK & COMPANY INCORPORATED
GSBD GOLDMAN SACHS BDC INC
FIS FIDELITY NATIONAL INFORMATION SERVICES INC.
CTAS CINTAS CORPORATION
CAG CONAGRA BRANDS INC.
BZUN BAOZUN INC SPONSORED ADR CLASS A
GAM GENERAL AMERICAN INVESTORS CO. INC.
SJW SJW GROUP
CULP CULP INC.
SCVL SHOE CARNIVAL INC.
CIA CITIZENS INC. CL A
FUL H.B. FULLER COMPANY
CRT CROSS TIMBERS ROYALTY TRUST
LW LAMB WESTON HOLDINGS INC.
NKE NIKE INC. CLASS B
PAGS PAGSEGURO DIGITAL LTD
FUND ROYCE FOCUS TRUST
FGBI INC.
NMM FIRST GUARANTY BANCSHARES
ENR NAVIOS MARITIME PARTNERS
SVC EDGEWELL PERSONAL CARE COMPANY
AIMD.P SERVICE PROPERTIES TRUST
CNXC AIM4 VENTURES
QFIN CONCENTRIX
VSCO 360 DIGITECH INC
SG VICTORIA'S SECRET & CO
HDB SWEETGREEN INC
IBRX HDFC BANK LTD
BEAT IMMUNITYBIO INC
MEGI HEARTBEAM INC
POCI MAINSTAY CBRE GBL INFRASTRUCTURE MEGATRENDS FD
BPRN PRECISION OPTICS CORP INC (MASS)
LPCN BANK OF PRINCETON
HYMC LIPOCINE INC
BETR HYCROFT MINING HOLDING CORPORATION
BNR BETTER HOME & FINANCE HOLDING COMPANY
VVOS BURNING ROCK BIOTECH LIMITED
MESO VIVOS THERAPEUTICS INC
USAU MESOBLAST LIMITED
COE USA URANIUM
COLUMBIA EQUITY TRUST
INC.
- Jonathan Moreland
- Jonathan Moreland
- Jonathan Moreland
BZUN BAOZUN INC SPONSORED ADR CLASS A
SNAP SNAP INC. CLASS A
NKE NIKE INC. CLASS B
ENR EDGEWELL PERSONAL CARE COMPANY
RPAY REPAY HOLDINGS (A)
DNA GINKGO BIOWORKS HOLDINGS
HYMC INC.
BETR HYCROFT MINING HOLDING CORPORATION
MESO BETTER HOME & FINANCE HOLDING COMPANY
USAU MESOBLAST LIMITED
USA URANIUM
Annexon to Present at the 25th Annual Needham Virtual Healthcare Confe...
Annexon to Present at the 25th Annual Needham Virtual Healthcare Conference BRISBANE, Calif., April 08, 2026 (GLOBE NEWSWIRE) -- Annexon, Inc. (Nasdaq: ANNX), a biopharmaceutical company advancing the next generation platform of targeted immunotherapies aimed at neuroinflammatory diseases that impact nearly 10 million people worldwide, today announced that Douglas Love, Esq., president and chief executive officer, will present at the 25th Annual Needham Virtual Healthcare Conference on Wednesday, April 15, 2026 at 11:45 a.m. ET. A live webcast of the event can be accessed under the ‘Even...
Maui Land & Pineapple Company, Inc. Reports Fiscal Year 2025 Results
Maui Land & Pineapple Company, Inc. Reports Fiscal Year 2025 Results KAPALUA, Hawai‘i , April 01, 2026 (GLOBE NEWSWIRE) -- Maui Land & Pineapple Company, Inc. (NYSE: MLP) today reported financial results covering the year ended December 31, 2025. “Our fiscal year 2025 results reflect significant progress in executing strategic initiatives, with operating revenues growing over 70% from last year. This growth was largely driven by higher recurring leasing revenue achieved through purposeful placemaking in our Kapalua and Hāli‘imaile town centers. These results were complemented by an incre...
Universal Technical Institute Inc: 1 director
A director at Universal Technical Institute Inc sold 23,654 shares at 37.546USD and the significance rating of the trade was 74/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last...
Annexon Reports Fourth Quarter and Year-End 2025 Financial Results, Po...
Annexon Reports Fourth Quarter and Year-End 2025 Financial Results, Portfolio Progress and Key Anticipated Milestones ARCHER II Topline Pivotal Phase 3 Data in Geographic Atrophy (GA) Expected Q4 2026; Vonaprument has Potential to Be the First Vision-Preserving Therapy for GA Tanruprubart MAA Filed in Europe with Potential to Be the First Targeted Fast-Acting Therapy for Guillain-Barré Syndrome (GBS); U.S./European FORWARD Study Data Expected to Support Planned BLA Submission in 2026 ANX1502 Advancing as First Oral C1 Inhibitor for Autoimmune Disease; Proof-of-Concept (POC) Data Anticipa...
- Dave Nicoski
- Ross LaDuke
Vermilion Compass: Weekly Equity Strategy
Significant Downside Risk if 6480 Breaks Our outlook (as of our 3/3/26 Compass) remains near-term neutral on the S&P 500 (SPX), after being bullish for all but one week since 4/22/25 (we went neutral 11/19/25-11/25/25). Our initial concerns that we discussed since early-February stemmed from deteriorating market dynamics, and ever since then we have been "concerned about a deeper pullback, likely to 6720-6776, 6690, or 6480-6520 on SPX." SPX hit 6480-6520 support on Friday and yesterday (Monday...
Annexon Reports Inducement Grant to New Employee Under Nasdaq Listing ...
Annexon Reports Inducement Grant to New Employee Under Nasdaq Listing Rule 5635(c)(4) BRISBANE, Calif., March 16, 2026 (GLOBE NEWSWIRE) -- Annexon, Inc. (Nasdaq: ANNX), a biopharmaceutical company advancing the next generation platform of targeted immunotherapies aimed at neuroinflammatory diseases that impact nearly 10 million people worldwide, today announced that it has granted inducement to a new non-executive employee under the terms of the 2022 Employment Inducement Award Plan. The equity award was approved on March 12, 2026, in accordance with Nasdaq Listing Rule 5635(c)(4). The n...
- Jonathan Moreland
WHR WHIRLPOOL CORPORATION
ANTM ANTHEM INC.
ZBRA ZEBRA TECHNOLOGIES CORPORATION CLASS A
XRAY DENTSPLY SIRONA INC.
TPC TUTOR PERINI CORPORATION
RUN SUNRUN INC.
NMFC NEW MOUNTAIN FINANCE CORPORATION
GPK GRAPHIC PACKAGING HOLDING COMPANY
FMNB FARMERS NATIONAL BANC CORP.
FFIN FIRST FINANCIAL BANKSHARES INC
DIN DINE BRANDS GLOBAL INC.
ACIW ACI WORLDWIDE INC.
WD WALKER & DUNLOP INC.
AUP AURINIA PHARMACEUTICALS INC.
SABR SABRE CORP.
TREX TREX COMPANY INC.
TTEC TELETECH HOLDINGS
SSP INC.
KKR THE E.W. SCRIPPS COMPANY
ENR KKR & CO. INC.
SMCI EDGEWELL PERSONAL CARE COMPANY
AHCO SUPER MICRO COMPUTER
DCTH INC.
TSLX ADAPTHEALTH
THRY DELCATH SYSTEMS
EOSE SIXTH STREET SPECIALTY LENDING
SLRC INC.
AGL THRYV HOLDINGS
PFX EOS ENERGY ENTERPRISES INC (A)
FA SOLAR CAPITAL LTD.
CMTG AGILON HEALTH
AIRS INC.
MYN PHENIXFIN CORP
TTD FIRST ADVANTAGE CORP NEW
FBRT CLAROS MORTGAGE TRUST
HR INC.
BLCO AIRSCULPT TECHNOLOGIES INC
EFSI BLACKROCK MUNIYELD N Y INSD FD INC
NRGV THE TRADE DESK
NMTC FRANKLIN BSP REALTY TRUST INC
CGON HEALTHCARE TRUST OF AMERICA INC.
NCDL BAUSCH + LOMB CORP
MSDL EAGLE FINANCIAL SERVICES INC
LAW ENERGY VAULT HOLDINGS INC
PMN NEUROONE MEDICAL TECHNOLOGIES CORP
CG ONCOLOGY INC
NUVEEN CHURCHILL DIRECT LENDING CORP
MORGAN STANLEY DIRECT LENDING
CS DISCO INC
PROMIS NEUROSCIENCES INC.
Annexon Biosciences to Present at the TD Cowen 46th Annual Health Care...
Annexon Biosciences to Present at the TD Cowen 46th Annual Health Care Conference BRISBANE, Calif., Feb. 24, 2026 (GLOBE NEWSWIRE) -- Annexon, Inc. (Nasdaq: ANNX), a biopharmaceutical company advancing the next generation platform of targeted immunotherapies aimed at neuroinflammatory diseases that impact nearly 10 million people worldwide, today announced that Douglas Love, Esq., president and chief executive officer, will present at the TD Cowen 46th Annual Health Care Conference on Tuesday, March 3, 2026 at 9:50 a.m. ET. A live webcast of the event can be accessed under the ‘Events & ...
Annexon to Host In-Person and Virtual KOL Event to Discuss Vonaprument...
Annexon to Host In-Person and Virtual KOL Event to Discuss Vonaprument for the Treatment of Geographic Atrophy BRISBANE, Calif., Feb. 17, 2026 (GLOBE NEWSWIRE) -- Annexon, Inc. (Nasdaq: ANNX), a biopharmaceutical company advancing the next generation platform of targeted immunotherapies aimed at neuroinflammatory diseases that impact nearly 10 million people worldwide, today announced that it will host an in-person and virtual key opinion leader (KOL) event in New York on Wednesday, March 18, 2026, with presentations at 2:00 PM ET and a reception at 4:00 PM ET. To register, . The event w...
Annexon Reports Inducement Grants to New Employees Under Nasdaq Listin...
Annexon Reports Inducement Grants to New Employees Under Nasdaq Listing Rule 5635(c)(4) BRISBANE, Calif., Jan. 16, 2026 (GLOBE NEWSWIRE) -- Annexon, Inc. (Nasdaq: ANNX), a biopharmaceutical company advancing the next generation platform of targeted immunotherapies aimed at neuroinflammatory diseases that impact nearly 10 million people worldwide, today announced that it has granted inducement to two new non-executive employees under the terms of the 2022 Employment Inducement Award Plan. The equity awards were approved on January 9, 2026, in accordance with Nasdaq Listing Rule 5635(c)(4)....
- Jonathan Moreland
Annexon Accelerating Next Generation Targeted Immunotherapy Platform f...
Annexon Accelerating Next Generation Targeted Immunotherapy Platform for Treatment of Neuroinflammatory Diseases with Multiple Registrational Milestones in 2026 Tanruprubart MAA Filed with Potential to Be the First Targeted Fast-Acting Therapy for Guillain-Barré Syndrome (GBS); BLA Submission with U.S./European Data Planned in 2026 Vonaprument Pivotal Phase 3 Topline Data for Dry AMD with Geographic Atrophy (GA) on Track for Second Half of 2026 Evaluating Unprecedented Effect on Vision Protection Proof-of-Concept Data for ANX1502, the First Oral C1 Inhibitor for Autoimmune Disease, Expect...
- Jonathan Moreland
Triplepoint Venture Growth Bdc Corp: 1 director
A director at Triplepoint Venture Growth Bdc Corp bought 47,710 shares at 6.493USD and the significance rating of the trade was 52/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the l...
Annexon Submits Tanruprubart Marketing Authorization Application to th...
Annexon Submits Tanruprubart Marketing Authorization Application to the European Medicines Agency for Guillain-Barré Syndrome Potential to Be the First Targeted Fast-Acting Therapy for GBS, Setting a New Standard of Care BLA Submission with U.S./European Data from FORWARD Trial Planned in 2026 BRISBANE, Calif., Jan. 08, 2026 (GLOBE NEWSWIRE) -- (Nasdaq: ANNX), a biopharmaceutical company advancing the next generation platform of targeted immunotherapies aimed at neuroinflammatory diseases that impact nearly 10 million people worldwide, today announced it has submitted a Marketing Auth...
- Jonathan Moreland
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.